Search results for "Prosthetic joint"

showing 5 items of 5 documents

Prosthetic joint infection caused by Mycobacterium avium complex.

2019

Aged 80 and overMaleProsthesis-Related Infectionsbiologybusiness.industryProsthetic joint infectionGeneral Medicinebiology.organism_classificationMycobacterium avium ComplexMicrobiologyFatal OutcomePositron-Emission TomographyMedicineHumansMycobacterium avium complexHip ProsthesisbusinessMycobacterium avium-intracellulare InfectionQJM : monthly journal of the Association of Physicians
researchProduct

Staphylococcus aureus bloodstream infection in patients with prosthetic joint included in the prospective VIRSTA cohort study: frequency and time of …

2019

International audience; Among 143 patients of the VIRSTA cohort study with Staphylococcus aureus bacteremia and an arthroplasty implanted for more than a year, S. aureus periprosthetic joint infection was observed in 19%. Signs of infection (pain and swelling) were always present, in median 1 day (range, 0-21 days) after onset of bacteremia. Staphylococcus aureus has both a high potential for metastatic infection and a high affinity for foreign material. Possible prosthesis infection is of clinical concern in all patients with preexisting prosthetic materials experiencing S. aureus bloodstream infection (SAB). Prosthetic joints are especially prone to infection during the course of bacterem…

0301 basic medicinemedicine.medical_specialtyStaphylococcus aureusmedicine.medical_treatment030106 microbiologyPeriprostheticbloodstream infectionmedicine.disease_causeProsthesis03 medical and health sciences0302 clinical medicineInternal medicinemedicine030212 general & internal medicineprosthetic joint infectionProspective cohort studybusiness.industryBrief Reportmedicine.diseaseArthroplasty3. Good healthInfectious DiseasesOncologyStaphylococcus aureusBacteremiaImplantbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyCohort study
researchProduct

bbFISH-ing in the sonication fluid

2019

Abstract By 2030, the annual number of combined total hip and knee arthroplasty is estimated to reach 3.5 to 4 million in the US alone. In the context of a constant increase of the number of primary and revision total hip and knee arthroplasty, an increased risk of complication is expected. Prosthetic joint infections (PJIs) represent major cause of healthcare expenditure and morbidity. PJI still remain the most common and feared arthroplasty complication. A rapid and correct diagnosis of infection is decisive for a correct therapeutical management. In this setting, the Academic Emergency Hospital Sibiu adopted and implemented, with the beginning of September 2016, a new strategy for the di…

sonicationMaleProsthetic joint infectionmedicine.medical_specialtyPJIProsthesis-Related InfectionsArthroplasty Replacement Hipmedicine.medical_treatmentSonication7100Observational StudydiagnosticContext (language use)biofilm03 medical and health sciences0302 clinical medicineStaphylococcus epidermidisRNA Ribosomal 16SInternal medicineSynovial FluidmedicineHumans030212 general & internal medicineArthroplasty Replacement KneeIn Situ Hybridization FluorescenceAgedAged 80 and overBacteriological Techniquesbiologybusiness.industryRalstonia pickettiimolecular diagnosticBacterial InfectionsGeneral MedicineGold standard (test)Middle Agedbiology.organism_classificationArthroplastyRNA BacterialConnective Tissue030220 oncology & carcinogenesisPositive culturebbFISHFemaleComplicationbusinessResearch ArticleMedicine
researchProduct

Mycobacterium tuberculosis prosthetic joint infections a case series and literature review

2018

International audience; Objectives - We aimed to characterize diagnosis, management, and outcome of Mycobacterium tuberculosis prosthetic joint infections (PJI).Methods - Cases of M. tuberculosis PJI documented in 7 referral French centers were retrospectively reviewed. Data were collected from medical files on a standardized questionnaire. We performed a literature review using the keywords 'prosthetic joint', and 'tuberculosis'. Results - During years 1997-2016, 13 patients (8 males, 5 females, median age 79 years [range, 60-86]) had documented M. tuberculosis PJI, involving hip (n = 6), knee (n = 6), or shoulder (n = 1). Median time from arthroplasty to diagnosis was 9 years [0.4-20]. Th…

Male0301 basic medicineArthroplasty Replacement Hipmedicine.medical_treatment0302 clinical medicine[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesSurveys and QuestionnairesMedicine030212 general & internal medicineFavorable outcomeArthroplasty Replacement KneeSurgical treatmentComputingMilieux_MISCELLANEOUShealth care economics and organizationsAged 80 and overbiologyDisease ManagementMiddle AgedAnti-Bacterial Agents3. Good healthInfectious Diseases[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyArthroplasty Replacement Shoulder[SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseasesFemaledebridementMicrobiology (medical)medicine.medical_specialtyProsthesis-Related InfectionsTuberculosisProsthetic joint030106 microbiologyeducationResectionMycobacterium tuberculosis03 medical and health sciencesantituberculosis drugResection arthroplastyHumansTuberculosisAgedRetrospective Studiesbusiness.industryProsthetic jointMycobacterium tuberculosismedicine.diseasebiology.organism_classificationArthroplastySurgeryarthroplastyJointsbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives

2021

INTRODUCTION: The COVID-19 pandemic has dramatically challenged the national health systems worldwide in the last months. Dalbavancin is a novel antibiotic with a long plasmatic half-life and simplified weekly administration regimens, thus representing a promising option for the outpatient treatment of Gram-positive infections and the early discharge of hospitalized patients. Dalbavancin is approved for the treatment of acute bacterial skin and skin structure infections (ABSSSIs). Many preliminary data seem to support its use in other indications, such as osteomyelitis, prosthetic joint infections, and infective endocarditis. AREAS COVERED: A search in the literature using validated keyword…

0301 basic medicineMicrobiology (medical)medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)medicine.drug_classProsthetic joint030106 microbiologyAntibioticsGram-Positive Bacterial InfectionABSSSIsMicrobiologyDrug Administration Scheduleosteomyelitis.endocarditi03 medical and health sciencesABSSSIs; COVID-19; dalbavancin; endocarditis; Gram-positive; long-acting; osteomyelitisGram-positive0302 clinical medicineVirologyPandemicAnti-Bacterial AgentmedicineAmbulatory CareAnimalsHumans030212 general & internal medicineIntensive care medicineGram-Positive Bacterial Infectionsbusiness.industryAnimalOsteomyelitisDalbavancinCOVID-19osteomyelitisSkin Diseases Bacteriallong-actingABSSSImedicine.diseaseAnti-Bacterial AgentsInfectious DiseasesInfective endocarditisSkin structureendocarditisosteomyelitiTeicoplaninbusinessdalbavancinHuman
researchProduct